Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.7 (
plasmin
)
9,023
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The heparin-binding affinity of the tetrameric
extracellular superoxide dismutase
(
EC-SOD
) is a result of the cooperative effect of the heparin-binding domains of the subunits, located in the hydrophilic, strongly positively charged C-terminal ends.
EC-SOD
C, the high-heparin-affinity type, exposed to immobilized trypsin and
plasmin
was found to rapidly lose its affinity for heparin, without any loss of enzymic activity or major change in molecular mass as judged by size-exclusion chromatography. Heparin and dextran sulphate 5000 inhibited the proteolysis, suggesting that
EC-SOD
C sequestered by heparan sulphate proteoglycan in vivo is partially protected against proteolysis. The loss of heparin-affinity occurred with the stepwise formation of intermediates, and the pattern upon chromatography on heparin-Sepharose and subsequent immunoblotting was compatible with the notion that the changes are due to sequential truncations of heparin-binding domains from subunits composing the
EC-SOD
tetramers. A similar pattern with intermediates and apparent truncations has previously been found with
EC-SOD
of human plasma. The findings show that the unique design of the heparin-binding domain of
EC-SOD
allows easy modification of the heparin-affinity by means of limited proteolysis, and suggest that such proteolysis is a major contributor to the heterogeneity in heparin-affinity of
EC-SOD
in mammalian plasma.
...
PMID:Proteolytic modification of the heparin-binding affinity of extracellular superoxide dismutase. 845 52